ClinicalTrials.govpublic full text
YM598 Added to Mitoxantrone/Prednisone to Control Pain in Metastatic Prostate Cancer Patients No Longer Responding to Hormone Therapy
hormone-refractory prostate cancer, prostatic neoplasms, androgen-independent prostate cancer, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 1046254
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.